Optimizing treatment of hypertension in patients with diabetes.
Cooper
M E
ME
Baker Medical Research Institute, Alfred Hospital, Commercial Road, Prahran, Australia. cooper@austin.unimelb.edu.au
Johnston
C I
CI
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000453:epidemiology / Q000517:prevention & control; D048909:Diabetes Complications; D006801:Humans; D006973:Hypertension / Q000150:complications* / Q000188:drug therapy*; D012307:Risk Factors
D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D002121:Calcium Channel Blockers